Statins for stronger smiles: gel may boost dental implant success
NCT ID NCT07194447
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether applying a gel containing simvastatin (a cholesterol drug) around new dental implants helps them heal stronger and reduces bone loss. Forty-two adults received implants and were randomly given either the simvastatin gel or a placebo gel. Implant stability was measured at 8 and 16 weeks, and bone levels were checked with a 3D X-ray. The goal was to see if the gel improves how the implant fuses with the jawbone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
42 people
The number who actually took part.
- Started
-
Oct 2024
- Finished
-
Jul 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Healthy patients ≥ 18 years of either gender. 2. Having missing teeth in maxillary jaw maxillary jaw( premolar and molar area) at least 6 months after teeth extraction. 3. Patients who had alveolar ridges of sufficient vertical and horizontal dimensions and were considered surgically straight forward cases according to SAC classification Exclusion Criteria: 1. Patients with signs of acute or chronic infection in the implant zone 2. Patients with signs of parafunctional habits 3. Patients with history of systemic diseases or recent radiotherapy to the head and neck or chemotherapy. 4. Patients who had history or were currently under treatment with oral or intravenous bisphosphonate or statins other drugs that may alter bone metabolism 5. Patients who are heavy smoker or presented with severe periodontitis. 6. Pregnant patients.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Dental implants , osseointegration , marginal bone loss , implant stability are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
College of Dentistry, University of Baghdad
Baghdad, Baghdad Governorate, 10071, Iraq
More trials for these conditions
Other studies related to the condition(s) this trial covers.